These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 2384978

  • 1. Antitumor activity of T-2 toxin-conjugated monoclonal antibody to murine thymoma.
    Ohtani K, Murakami H, Shibuya O, Kawamura O, Ohi K, Chiba J, Otokawa M, Ueno Y.
    Jpn J Exp Med; 1990 Apr; 60(2):57-65. PubMed ID: 2384978
    [Abstract] [Full Text] [Related]

  • 2. Antitumor effect of 2'-deoxy-5-fluorouridine conjugates against a murine thymoma and colon carcinoma xenografts.
    Krauer KG, McKenzie IF, Pietersz GA.
    Cancer Res; 1992 Jan 01; 52(1):132-7. PubMed ID: 1530766
    [Abstract] [Full Text] [Related]

  • 3. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.
    Hara H, Luo Y, Haruta Y, Seon BK.
    Cancer Res; 1988 Aug 15; 48(16):4673-80. PubMed ID: 2969282
    [Abstract] [Full Text] [Related]

  • 4. Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction.
    Zubler RH, Erard F, Lees RK, Van Laer M, Mingari C, Moretta L, MacDonald HR.
    J Immunol; 1985 Jun 15; 134(6):3662-8. PubMed ID: 3886789
    [Abstract] [Full Text] [Related]

  • 5. Enhanced antitumour effects using a combination of two antibodies conjugated to different drugs.
    Rowland AJ, McKenzie IF, Pietersz GA.
    J Drug Target; 1994 Jun 15; 2(2):113-21. PubMed ID: 8069589
    [Abstract] [Full Text] [Related]

  • 6. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE, Brown AN, Bremner JA, Foxwell BM, Stirpe F.
    J Natl Cancer Inst; 1985 Jul 15; 75(1):151-9. PubMed ID: 3859688
    [Abstract] [Full Text] [Related]

  • 7. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T.
    Cancer Res; 1988 Mar 01; 48(5):1173-9. PubMed ID: 3257715
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
    Safavy A, Bonner JA, Waksal HW, Buchsbaum DJ, Gillespie GY, Khazaeli MB, Arani R, Chen DT, Carpenter M, Raisch KP.
    Bioconjug Chem; 2003 Mar 01; 14(2):302-10. PubMed ID: 12643740
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
    Manzke O, Russello O, Leenen C, Diehl V, Bohlen H, Berthold F.
    Med Pediatr Oncol; 2001 Jan 01; 36(1):185-9. PubMed ID: 11464879
    [Abstract] [Full Text] [Related]

  • 10. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.
    Endo N, Takeda Y, Umemoto N, Kishida K, Watanabe K, Saito M, Kato Y, Hara T.
    Cancer Res; 1988 Jun 15; 48(12):3330-5. PubMed ID: 3259466
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.
    Kim JA, Averbook BJ, Chambers K, Rothchild K, Kjaergaard J, Papay R, Shu S.
    Cancer Res; 2001 Mar 01; 61(5):2031-7. PubMed ID: 11280763
    [Abstract] [Full Text] [Related]

  • 15. Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates.
    Pietersz GA, Smyth MJ, McKenzie IF.
    Cancer Res; 1988 Feb 15; 48(4):926-31. PubMed ID: 3422182
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H, Moroyama T, Mendelsohn J.
    Cancer Res; 1986 Nov 15; 46(11):5592-8. PubMed ID: 3756906
    [Abstract] [Full Text] [Related]

  • 18. Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells.
    May KF, Chen L, Zheng P, Liu Y.
    Cancer Res; 2002 Jun 15; 62(12):3459-65. PubMed ID: 12067989
    [Abstract] [Full Text] [Related]

  • 19. Internalization of phosphatidylinositol-anchored lymphocyte proteins. I. Documentation and potential significance for T cell stimulation.
    Bamezai A, Goldmacher V, Reiser H, Rock KL.
    J Immunol; 1989 Nov 15; 143(10):3107-16. PubMed ID: 2572642
    [Abstract] [Full Text] [Related]

  • 20. Effect of Fusarium toxins, T2-toxin and diacetoxyscirpenol on murine T-independent immune responses.
    Rosenstein Y, Kretschmer RR, Lafarge-Frayssinet C.
    Immunology; 1981 Nov 15; 44(3):555-60. PubMed ID: 6976308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.